Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)
China
· Delayed Price · Currency is CNY 106.62
-0.39 (-0.36%)
Mar 10, 2026, 9:25 AM CST
SHE:300436 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 16,981 | 5,203 | 4,082 | 6,237 | 7,626 | 5,410 | Upgrade
|
| Market Cap Growth | 219.99% | 27.47% | -34.55% | -18.22% | 40.97% | 16.00% | Upgrade
|
| Enterprise Value | 17,257 | 5,570 | 4,394 | 6,256 | 7,352 | 5,526 | Upgrade
|
| Last Close Price | 106.62 | 32.67 | 25.63 | 39.16 | 48.03 | 38.64 | Upgrade
|
| PE Ratio | - | - | - | - | - | 364.91 | Upgrade
|
| Forward PE | - | 46.43 | 46.43 | 46.43 | 46.43 | 46.43 | Upgrade
|
| PS Ratio | 39.40 | 11.79 | 9.66 | 16.17 | 20.59 | 14.68 | Upgrade
|
| PB Ratio | 36.25 | 13.11 | 7.17 | 6.53 | 7.26 | 9.30 | Upgrade
|
| P/TBV Ratio | 172.23 | 105.00 | 24.67 | 8.11 | 8.81 | 12.71 | Upgrade
|
| P/OCF Ratio | - | 251.27 | - | - | - | 346.83 | Upgrade
|
| EV/Sales Ratio | 40.04 | 12.62 | 10.39 | 16.22 | 19.85 | 15.00 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | - | 151.23 | Upgrade
|
| EV/FCF Ratio | -312.15 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.93 | 1.12 | 0.81 | 0.33 | 0.18 | 0.36 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | - | 5.78 | Upgrade
|
| Net Debt / Equity Ratio | 0.41 | 0.75 | 0.45 | 0.08 | -0.20 | 0.13 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.51 | -9.89 | -1.83 | -0.43 | 7.04 | 2.06 | Upgrade
|
| Net Debt / FCF Ratio | -3.44 | -6.45 | -0.68 | -0.23 | 1.07 | -1.93 | Upgrade
|
| Asset Turnover | 0.28 | 0.29 | 0.27 | 0.26 | 0.30 | 0.39 | Upgrade
|
| Inventory Turnover | 1.36 | 1.79 | 2.07 | 2.16 | 2.09 | 2.83 | Upgrade
|
| Quick Ratio | 0.62 | 0.42 | 0.50 | 0.72 | 1.50 | 0.64 | Upgrade
|
| Current Ratio | 1.03 | 0.71 | 0.75 | 0.97 | 1.82 | 0.88 | Upgrade
|
| Return on Equity (ROE) | -45.15% | -35.71% | -49.17% | -14.02% | -4.19% | 2.85% | Upgrade
|
| Return on Assets (ROA) | -6.83% | -5.11% | -8.53% | -9.56% | -4.13% | -0.05% | Upgrade
|
| Return on Invested Capital (ROIC) | -25.06% | -16.40% | -22.88% | -24.04% | -10.80% | -0.12% | Upgrade
|
| Return on Capital Employed (ROCE) | -16.80% | -14.40% | -20.90% | -20.70% | -7.10% | -0.10% | Upgrade
|
| Earnings Yield | -1.16% | -3.00% | -8.54% | -2.04% | -0.46% | 0.27% | Upgrade
|
| FCF Yield | -0.33% | -0.89% | -9.21% | -5.06% | -2.52% | -0.72% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 59.62% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | 0.00% | -0.06% | -6.54% | -6.43% | -0.24% | Upgrade
|
| Total Shareholder Return | 0.01% | 0.00% | -0.06% | -6.54% | -6.43% | -0.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.